Article
Perillyl alcohol-mediated inhibition of lung cancer cell line proliferation: potential mechanisms for its chemotherapeutic effects.
Toxicology and applied pharmacology - 1 Mar 2004
Xu Mian, Floyd Heather S, Greth Suzanne M, Chang Wen-Chi L, Lohman Kurt, Stoyanova Radka, Kucera Gregory L, Kute Tim E, Willingham Mark C, Miller Mark Steven
Abstract excerpt
Perillyl alcohol (POH) is currently being tested in clinical trials as an anticancer agent, though its mechanism of action has not been definitively established. We treated two human lung cancer cell lines, H322 and H838, with POH to determine its antitumor properties. A sulforhodamine B (SRB) cell proliferation assay was used to determine the effects of POH after 1 and 5 days of treatment with 0.25, 0.5, 0.75,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
